Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

R. Kos (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Neerincx (Amsterdam, Netherlands), T. Paff (Amsterdam, Netherlands), M. Gerritsen (Amsterdam, Netherlands), A. Lammers (Amsterdam, Netherlands), A. Kraneveld (Utrecht, Netherlands), H. Heijerman (Utrecht, Netherlands), J. Davies (London, United Kingdom), H. Janssens (Rotterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands)

Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Session: Microbiology and antimicrobial strategies in cystic fibrosis
Session type: E-poster session
Number: 685
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Kos (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Neerincx (Amsterdam, Netherlands), T. Paff (Amsterdam, Netherlands), M. Gerritsen (Amsterdam, Netherlands), A. Lammers (Amsterdam, Netherlands), A. Kraneveld (Utrecht, Netherlands), H. Heijerman (Utrecht, Netherlands), J. Davies (London, United Kingdom), H. Janssens (Rotterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands). Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients. 685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018




Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
Source: ERJ Open Res 2015; 1: 00044-2015
Year: 2015



Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003

Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
Source: Eur Respir J 2016; 47: 994-997
Year: 2016


Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis
Source: Eur Respir J 2011; 37: 553-558
Year: 2011



Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004



Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
Source: ERJ Open Res, 7 (1) 00513-2020; 10.1183/23120541.00513-2020
Year: 2021



Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Detection of antibodies against Pseudomonas aeruginosa in the sputum of cystic fibrosis patients: A pilot study
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012

The sensitivity and specificity of pseudomonas aeruginosa detection using hydrogen cyanide concentration in exhaled breath – The SPACE study
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008



Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis
Source: Eur Respir J, 50 (4) 1701086; 10.1183/13993003.01086-2017
Year: 2017



Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017




Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Longitudinal examination of bronchiectasis sputum allows the early Pseudomonas aeruginosa detection
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019